MedPath

Correlation between inhibited gastric secretion level and residual symptoms in GERD patients refractory to PPI

Not Applicable
Recruiting
Conditions
GERD patients on ordinary dose of PPI
Registration Number
JPRN-UMIN000017347
Lead Sponsor
Division of Gastroenterology, Tohuku University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1. PPI compliance lower that 90% 2. taking other anti-secretory drugs, prokinetics, or anti-psychotis 3. GERD afer upper GI surgery 4. long-segment (more than 3 cm) Barrett's esophagus 5. taking NSAIDs or aspirin 6 receiving H. pylori eradication within 1 year 7. serious systematic diseases

Study & Design

Study Type
Interventional,observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of gastric acid secretion during PPI administration between GERD patients with and those without residual symptoms
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath